176 related articles for article (PubMed ID: 31601833)
21. Elevated FAM83A expression predicts poorer clincal outcome in lung adenocarcinoma.
Zhang J; Sun G; Mei X
Cancer Biomark; 2019; 26(3):367-373. PubMed ID: 31594212
[TBL] [Abstract][Full Text] [Related]
22. Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma.
Chen D; Luo L; Liang C
PLoS One; 2018; 13(5):e0197402. PubMed ID: 29746588
[TBL] [Abstract][Full Text] [Related]
23. Over-expression of Orai1 mediates cell proliferation and associates with poor prognosis in human non-small cell lung carcinoma.
Zhan ZY; Zhong LX; Feng M; Wang JF; Liu DB; Xiong JP
Int J Clin Exp Pathol; 2015; 8(5):5080-8. PubMed ID: 26191202
[TBL] [Abstract][Full Text] [Related]
24. Minichromosome maintenance protein 10 as a marker for proliferation and prognosis in lung cancer.
Wang M; Xie S; Yuan W; Xie T; Jamal M; Huang J; Yin Q; Song H; Zhang Q
Int J Oncol; 2019 Dec; 55(6):1349-1360. PubMed ID: 31638210
[TBL] [Abstract][Full Text] [Related]
25. HSP90B1 overexpression predicts poor prognosis in NSCLC patients.
Xu Y; Chen Z; Zhang G; Xi Y; Sun R; Wang X; Wang W; Chai F; Li X
Tumour Biol; 2016 Oct; 37(10):14321-14328. PubMed ID: 27599983
[TBL] [Abstract][Full Text] [Related]
26. ANCCA protein expression is a novel independent poor prognostic marker in surgically resected lung adenocarcinoma.
Zhang Y; Sun Y; Li Y; Fang Z; Wang R; Pan Y; Hu H; Luo X; Ye T; Li H; Wang L; Chen H; Ji H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S577-82. PubMed ID: 23775406
[TBL] [Abstract][Full Text] [Related]
27. High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients.
Ludovini V; Bellezza G; Pistola L; Bianconi F; Di Carlo L; Sidoni A; Semeraro A; Del Sordo R; Tofanetti FR; Mameli MG; Daddi G; Cavaliere A; Tonato M; Crinò L
Ann Oncol; 2009 May; 20(5):842-9. PubMed ID: 19153117
[TBL] [Abstract][Full Text] [Related]
28. Elevated mRNA Levels of AURKA, CDC20 and TPX2 are associated with poor prognosis of smoking related lung adenocarcinoma using bioinformatics analysis.
Zhang MY; Liu XX; Li H; Li R; Liu X; Qu YQ
Int J Med Sci; 2018; 15(14):1676-1685. PubMed ID: 30588191
[No Abstract] [Full Text] [Related]
29. High expression of long non-coding RNA ATB indicates a poor prognosis and regulates cell proliferation and metastasis in non-small cell lung cancer.
Ke L; Xu SB; Wang J; Jiang XL; Xu MQ
Clin Transl Oncol; 2017 May; 19(5):599-605. PubMed ID: 27878433
[TBL] [Abstract][Full Text] [Related]
30. BZW1 is a prognostic and immunological biomarker in pancreatic adenocarcinoma.
Luo A; Qiao N; Hu K; Xu H; Xie M; Jiang Y; Hu J
Medicine (Baltimore); 2024 Feb; 103(5):e37092. PubMed ID: 38306570
[TBL] [Abstract][Full Text] [Related]
31. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.
Huang Q; Fan J; Qian X; Lv Z; Zhang X; Han J; Wu F; Chen C; Du J; Guo M; Hu G; Jin Y
J Cancer Res Clin Oncol; 2016 Jan; 142(1):263-72. PubMed ID: 26319393
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of nuclear factor of activated T-cells 5 expression in non-small cell lung cancer patients who underwent surgical resection.
Cho HJ; Yun HJ; Yang HC; Kim SJ; Kang SK; Che C; Lee SD; Kang MW
J Surg Res; 2018 Jun; 226():40-47. PubMed ID: 29661287
[TBL] [Abstract][Full Text] [Related]
33. Relationships of hHpr1/p84/Thoc1 expression to clinicopathologic characteristics and prognosis in non-small cell lung cancer.
Yang J; Li Y; Khoury T; Alrawi S; Goodrich DW; Tan D
Ann Clin Lab Sci; 2008; 38(2):105-12. PubMed ID: 18469354
[TBL] [Abstract][Full Text] [Related]
34. Loss of thymidine kinase 1 inhibits lung cancer growth and metastatic attributes by reducing GDF15 expression.
Malvi P; Janostiak R; Nagarajan A; Cai G; Wajapeyee N
PLoS Genet; 2019 Oct; 15(10):e1008439. PubMed ID: 31589613
[TBL] [Abstract][Full Text] [Related]
35. Overexpressed LAPTM4B-35 is a risk factor for cancer recurrence and poor prognosis in non-small-cell lung cancer.
Kong F; Gao F; Chen J; Sun Y; Zhang Y; Liu H; Li X; Yang P; Zheng R; Liu G; Jia Y
Oncotarget; 2016 Aug; 7(35):56193-56199. PubMed ID: 27486880
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC).
Liu YZ; Jiang YY; Hao JJ; Lu SS; Zhang TT; Shang L; Cao J; Song X; Wang BS; Cai Y; Zhan QM; Wang MR
Lung Cancer; 2012 Jul; 77(1):176-82. PubMed ID: 22456526
[TBL] [Abstract][Full Text] [Related]
37. Prognostic impact of GATA binding protein-3 expression in primary lung adenocarcinoma.
Hashiguchi T; Miyoshi H; Nakashima K; Yokoyama S; Matsumoto R; Murakami D; Mitsuoka M; Takamori S; Akagi Y; Ohshima K
Hum Pathol; 2017 May; 63():157-164. PubMed ID: 28322854
[TBL] [Abstract][Full Text] [Related]
38. ZWINT is the next potential target for lung cancer therapy.
Peng F; Li Q; Niu SQ; Shen GP; Luo Y; Chen M; Bao Y
J Cancer Res Clin Oncol; 2019 Mar; 145(3):661-673. PubMed ID: 30643969
[TBL] [Abstract][Full Text] [Related]
39. Follistatin-like Protein 1 Inhibits Lung Cancer Metastasis by Preventing Proteolytic Activation of Osteopontin.
Chiou J; Chang YC; Tsai HF; Lin YF; Huang MS; Yang CJ; Hsiao M
Cancer Res; 2019 Dec; 79(24):6113-6125. PubMed ID: 31653686
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
